Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome-Reference-Cited by-同舟云学术

Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome

Published:2017-05-09 Issue:12 Volume:58 Page:2799-2810
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Shanmuganathan Naranie¹²³⁴^ORCID,Hiwase Devendra Keshaorao¹²³⁴,Ross David Morrall¹²³⁴⁵^ORCID

Affiliation:

1. Department of Haematology, Royal Adelaide Hospital, Adelaide, South Australia, Australia;

2. Department of Haematology, SA Pathology, Adelaide, South Australia, Australia;

3. Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia;

4. School of Medicine, University of Adelaide, Adelaide, South Australia, Australia;

5. Department of Haematology, Flinders University and Medical Centre, Bedford Park, South Australia, Australia

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1312377

Reference92 articles.

1. Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

2. NCCN Clinical Practice Guidelines in Oncology: Chronic Myelogenous Leukemia (version 1.2017) Fort Washington, PA2017 [2016 Dec 12]. Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.

3. Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

4. Chronic Myeloid Leukemia – SEER Stat Fact Sheets 2016 [cited 2016 May 25]. Available from: http://seer.cancer.gov/statfacts/html/cmyl.html.

5. Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycogen Synthase Kinase 3 Promotes Tyrosine Kinase Inhibitor-Induced Apoptosis in Philadelphia Chromosome-Positive Leukemia Cells by Regulating the Wnt/β-Catenin Pathway;J BIOL REG HOMEOS AG;2023

2. Chronic Myeloid Leukemia: A retrospective study of clinical and pathological features;Bionatura;2022-09-15

3. Anticancer potential of mebendazole against chronic myeloid leukemia: in silico and in vitro studies revealed new insights about the mechanism of action;Frontiers in Pharmacology;2022-08-25

4. A systematic review and meta-analysis on the risk factors of acute myeloid leukemia;Translational Cancer Research;2022-04

5. HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis;Cell Death & Disease;2022-01-28